Settlement Status: Payments Sent
Claim Form Deadline: Passed
Proof Required: No
Payment Method: Mailed Check
Overview of the EpiPen Settlement
As of June 28, 2023, claimants in the EpiPen class action have reported receiving payments of up to $1,500. Payments were made through a digital payment portal, offering options such as a virtual prepaid MasterCard, PayPal, direct deposit, or Venmo.
The settlement, totaling $264 million, arose from a lawsuit against manufacturers of EpiPens, including Mylan N.V., Mylan Specialty L.P., Mylan Pharmaceuticals Inc., Viatris Inc., and Heather Bresch. The EpiPen Class Action Settlement is now closed to new claims. Here’s what you need to know:
Eligible claimants were notified via email at the address provided in their Claim Form. This initial email contained instructions for redeeming payments through a digital process, with distributions expected to occur between June 14 and June 19, 2023. If you qualified for the settlement, check for an email from payments@mail.epipenclassaction.com.
Following the initial email, a second message will be sent with a live link to redeem the digital payment and details regarding the payment amount. Note that specifics on payment amounts will only be available after the second email is received.
Important: This EpiPen settlement is distinct from a prior class action against Pfizer, which resulted in a larger $345 million settlement. The earlier lawsuit alleged that EpiPen manufacturers engaged in practices violating state antitrust and federal racketeering laws, harming competition and causing consumers to overpay. Mylan, while denying any wrongdoing, agreed to establish a $264 million settlement fund.
Eligibility Requirements
The court has certified the following groups as eligible for the $264 million settlement:
- Individuals or entities in the U.S. who paid for or were reimbursed for the purchase price of branded or authorized generic EpiPens for personal use (not for resale) at any time from August 24, 2011, to November 1, 2020.
- Residents in specific “Antitrust States” (Alabama, California, Florida, Hawaii, Illinois, Kansas, Maine, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New York, North Carolina, Tennessee, and Utah) who paid for branded EpiPens between January 28, 2013, and November 1, 2020, also for personal use.
How to Find Class Action Settlements
Stay informed about the latest class action settlements and find out if you qualify for any by signing up for notifications on new lawsuits as they open for claims.
Please be aware that your claim form will be rejected if it contains fraudulent information. By submitting your information and your sworn statement of its accuracy, you are agreeing to do so under penalty of perjury. Submitting false information not only jeopardizes your claim but also affects others who are genuinely eligible for the settlement. If you are uncertain about your eligibility for this class action settlement, please visit the class action administrator’s website for more information. Note that NoProofClassActions.org participates in the Amazon affiliate advertising program, and this post may include affiliate links, which could result in us earning a commission if you make a purchase through those links.
